A healthcare executive with 25+ years leading corporate acquisitions and large-scale integrations across medical devices and life sciences, Ariel expands Boomerang’s reach in the Western-U.S. medtech ecosystem, advising on deal sourcing, diligence, portfolio management, strategic partnerships, and founder mentoring. She brings deep operational expertise in scaling and stabilizing business units and serves on the Boomerang Studio Board of Directors.
Previously, Ariel was at Medtronic’s Respiratory Interventions division (formerly Covidien), serving as president of the approximately $1B operating unit, leading a team of 400+, and driving the company’s acquisitions of Aircraft Medical and SonarMed. Earlier, she held senior marketing and regulatory roles at Johnson & Johnson.
MBA International Business | University of South Carolina
BA History | Dartmouth College
